Associate Professor Mehmet Hilmi Doğu was born in Tarsus in 1981. He graduated from Tarsus AKBAL Anatolian High School in 1999 and Ege University Faculty of Medicine in 2005. Between 2006- 2011, he completed his Internal Diseases specialization training at Pamukkale University Faculty of Medicine between 2011-2014 Hematology specialization training at the same university. During his hematology education, he attended PRAG on flowcytometry in hematological malignancies at ESCCA summer school. He worked at the Istanbul EAH Hematology clinic between 2015-2020 and assumed the Clinical Chef for 5 ye...
Associate Professor Mehmet Hilmi Doğu was born in Tarsus in 1981. He graduated from Tarsus AKBAL Anatolian High School in 1999 and Ege University Faculty of Medicine in 2005. Between 2006- 2011, he completed his Internal Diseases specialization training at Pamukkale University Faculty of Medicine between 2011-2014 Hematology specialization training at the same university. During his hematology education, he attended PRAG on flowcytometry in hematological malignancies at ESCCA summer school. He worked at the Istanbul EAH Hematology clinic between 2015-2020 and assumed the Clinical Chef for 5 years. Receiving the title of Associate Professor in 2018, Dr. Doğu, also served as an Education member. He has served as Principal Investigator and Associate Investigator in many phases 2 and phase 3 clinical trials and registry studies. More than 50 international and 30 national publications have received more than 500 citations. In addition, there are paper awards at the congress. He is currently working as a hematology specialist at Ulus Liv Hospital.
Articles
Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study ,2019
Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy ,2017
Stem cell mobilization kinetics in elderly patients with multiple myeloma ,2018
The Turkish experience with therapeutic plasma exchange: A national survey ,2019
The Turkish experience with therapeutic plasma exchange: A national survey. ,2019
The Turkish experience with therapeutic plasma exchange: A nationalsurvey ,2019
Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study ,2020
Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study ,2019
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience ,2017
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience ,2020
Nodular lymphocyte predominant Hodgkin’xxs lymphoma in dailypractice: A multicenter experience ,2018
Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study ,2019
Clinical characteristics and treatments outcomes in elderly patients with multiple myeloma:A multicenter retrospective study ,2017
Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study ,2019
Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma ,2020
Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study ,2019
The association of globulin levels with treatment response and survival in multiple myeloma patients ,2017
Vitamin D Deficiency and its Effects on Patients with Multiple Myeloma ,2017
The association of mean platelet volume and platecrit and bone marrow fibrosis in patients with essential thrombocythemia: A cohort study ,2019
Nodular Lymphocyte Predominant Hodgkin’s Lymphoma in Daily Practice: A Multicenter Experience ,2018
Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients ,2019
Evaluation of the reliability of interim PET/CT in the Hodgkin Lymphoma ,2019
The Impact of Bulky Mass on Treatment Response and Overall Survival in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era ,2018
Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis ,2017
Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma ,2017
Stem cell mobilization kinetics in elderly patients with multiple myeloma ,2018
The seasonality in the diagnosis of acute leukemia: A single center data from Turkey ,2018
Comparison of clinical features and survival between young and old chronic lymphocytic leukemia patients: a single center study from Turkey ,2018
Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience ,2017
Autologous Stem Cell Transplantation and Stem Cell Mobilization Kinetics in Elderly Patients with B Cell non-Hodgkin Lymphoma ,2017
Efficacy of CLARA in Recurrent/Refractory Acute Myeloid Leukaemia Patients Unresponsive to FLAG Chemotherapy ,2018
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience ,2017
Clinical Characteristics and Treatments Outcomes in Elderly Patients with Multiple Myeloma: A Multicenter Retrospective Study ,2017
Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma ,2017
Nodular lymphocyte predominant Hodgkin’s lymphoma in daily practice: A multicenter experience ,2017
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. ,2017
Dehydroepiandrosterone sulfate levels in Turkish obese patients ,2014
The association of globulin levels with treatment response and survival in multiple myeloma patients
Subfoveal Choroidal Thickness Is Associated with Blood Hematocrit Level ,2015
Relationship between Neutrophil-Lymphocyte Ratio and Clinicopathological Parameters in Follicular Lymphoma ,2016
Antitrombosit Ajanlar ,2016
Changes in serologic markers of hepatitis B in autologous hematopoietic stem cell transplantation recipients ,2016
Analysis of plateletpheresis donor deferral rate, characteristics, and its preventability ,2017
Vitamin D Deficiency and its Effects on Patients with Multiple Myeloma ,2017
Clinical Characteristics and Treatments Outcomes in Elderly Patients with Multiple Myeloma: A Multicenter Retrospective Study ,2017
UNUSUAL RESPONSE TO ELTROMBOPAG AND DOSE ADJUSTMENT IN PATIENT WITH A DIAGNOSIS OF REFRACTORY IMMUNE THROMBOCYTOPENIA ,2016
Contribution of MLPA to routine testing todetect the prognostic chromosomal abnormalitiesin chronic lymphocytic leukemia ,2014
T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis ,2016
Dramatic response in the dependency to transfusion after low doses of lenalidomide treatment in a 5q-syndrome patient: a case report ,2015
Olağandışı Ekstranodal T utulumlarla Agresif SeyredenMantle Hücreli Lenfoma ,2016
A Rare Cause of Bleeding Disorder in Pregnancy: Late Diagnosed Factor VII Deficiency: Case Report ,2015
Cutaneous adverse effects of imatinib mesylate ,2015
A Drug Used in The Treatment of Immune Thrombocytopenia Eltrombopag Might Be Cause of Pseudothrombocytopenia?: A Case Report ,2014
Alternative Treatment Option Therapeutic Apheresis Diagnosis and Clinical Approach 5 Year Experience ,2017
Platelet apheresis donation: Demographic findings, processing and harvest properties ,2015
Two rare diagnoses during chronic lymphocytic leukaemia follow-up: Kaposi’s sarcoma and Merkel cell carcinoma ,2016
CLINICAL CHARACTERISTICS, POST-TREATMENT ASSESSMENT AND PROGNOSTIC FACTORSAFFECTING PATIENT SURVIVAL OF PATIENTS AT 65 YEARS OF AGE OR OLDER WITH HODGKINLYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TURKEY ,2015
A Primary Bone Diffuse Large B-Cell Lymphoma with Ocular Adnexal Involvement ,2016
Successful Treatment of Refractory Gastrointestinal Bleeding by Systemic (Oral) Ankaferd Blood Stopper in a Patient with Glanzmann Thrombasthenia ,2015
A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination ,2016
Retinal vessel caliber, choroidal thickness and ocular pulse amplitude measurements in essential thrombocythemia ,2016
MYD88 Expression and L265P Mutation in Mature B-Cell Non-Hodgkin Lymphomas ,2015
Possible Role of GADD45γ Methylation in Diffuse Large B-Cell Lymphoma: Does It Affect the Progression and Tissue Involvement? ,2015
Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study ,2016
Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy ,2015
The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study ,2016
Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience ,2016
The effect of pneumatic tube system on complete blood count parameters and thrombocyte donation in healthy donors ,2012
The effect of gradual increment in rhG-CSF dose on stem cell yields in patients with multiple myeloma mobilized with intermediate dose cyclophosphamide plus rhG-CSF ,2014
Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study ,2015
Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis ,2013
Evaluation of neutrophil–lymphocyte ratio in patients with early-stage mycosis fungoides ,2016
Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma ,2017
Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation? ,2016
Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis ,2017
Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation? ,2016
Reports
Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey - FERHANOĞLU AHMET BURHAN,BEKÖZ HÜSEYİN SAFFET,KARADURMUŞ NURİ,PAYDAŞ SEMRA,GÜLBAŞ ZAFER,TÜRKER FATMA ALEV,TOPTAŞ TAYFUR,TUĞLULAR AYŞE TÜLİN,TEKGÜNDÜZ EMRE,KAYA ALİ HAKAN,ARAT MUTLU,TASTEMİR NAZLI,PEPEDİL TANRIKULU FUNDA,ÖZKOCAMAN VİLDAN,ABALI HÜSEYİN,TURGUT MEHMET,KAYNAR LEYLAGÜL,KARADOĞAN İHSAN,ÖZBALAK MUSTAFA MURAT,ÖZCAN MUHİT,DOĞU MEHMET HİLMİ,KABUKÇU HACIOĞLU SİBEL,YILDIRIM RAHŞAN,BARIŞTA İBRAHİM,DEMİRKAYA METİN,DİLAN KÖSEOĞLU FATOŞ,KURT YÜKSEL MELTEM,SÖNMEZ MEHMET,TOPRAK SELAMİ KOÇAK
Akut Lenfoblastik Lösemi, Türkiye Kayıt Çalışması - SEVİNDİK ÖMÜR GÖKMEN,BÜYÜKAŞIK YAHYA,TEKGÜNDÜZ EMRE,ERKURT MEHMET ALİ,VURAL FİLİZ,TURGUT BURHAN,KAYNAR LEYLAGÜL,PAYZIN KADRİYE BAHRİYE,DOĞU MEHMET HİLMİ,KARAKUŞ VOLKAN,DEMİRKAN FATİH
Nüks veya Refrakter Hodgkin Lenfoma Hastalarında Nivolumab Kullanımı Türkiye Verileri - FERHANOĞLU AHMET BURHAN, BEKÖZ HÜSEYİN SAFFET, KARADURMUŞ NURİ, PAYDAŞ SEMRA, TÜRKER ALEV, TOPTAŞ TAYFUR, TUĞLULAR AYŞE TÜLİN, SÖNMEZ MEHMET, GÜLBAŞ ZAFER, TEKGÜNDÜZ EMRE, KAYA ALİ HAKAN, ÖZBALAK MURAT, TAŞDEMİR NAZ, KAYNAR LEYLAGÜL, YILDIRIM RAHŞAN, KARADOĞAN İHSAN, ARAT MUTLU, PEPEDİL TANRIKULU FUNDA, ÖZKOCAMAN VİLDAN, ABALI HÜSEYİN, TURGUT MEHMET, KURT YÜKSEL MELTEM, ÖZCAN MUHİT, DOĞU MEHMET HİLMİ, HACIOĞLU SİBEL, BARIŞTA İBRAHİM, DEMİRKAYA METİN, KÖSEOĞLU FATOŞ DİLAN, TOPRAK SELAMİ KOÇAK, YILMAZ MEHMET, DEMİRKÜREK HÜSEYİN CENGİZ, DEMİRKOL MEHMET ONUR
Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey - FERHANOĞLU AHMET BURHAN,BEKÖZ HÜSEYİN SAFFET,KARADURMUŞ N,PAYDAŞ S,GÜLBAŞ Z,TÜRKER A,TOPTAŞ TAYFUR,TEKGÜNDÜZ E,KAYA AH,TAŞDEMİR N,ARAT MUTLU,TURGUT M,KAYNAR L,ÖZCAN MUHİT,DOĞU MEHMET HİLMİ,YILDIRIM R,DEMİRKAYA METİN,FD KÖSEOĞLU,YÜKSEL MELTEM,SÖNMEZ M,TOPRAK SELAMİ KOÇAK
BRENTUXIMAB VEDOTIN CONSOLIDATION THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK HODGKIN’xxS LYMPHOMA: MULTI-CENTER REAL-LIFE EXPERIENCE - FERHANOĞLU AHMET BURHAN,ALTUNTAŞ FEVZİ,ÖZBALAK MUSTAFA MURAT,Yıldız Birol,Yiğenoğlu Tuğçe Nur,YÖNAL HİNDİLERDEN İPEK,GÖKSOY HASAN SAMİ,Güner Şebnem İzmir,Güneş Ahmet Kürşad,SÖNMEZ MEHMET,YÜKSEL MELTEM,KAYNAR LEYLAGÜL,DOĞU MEHMET HİLMİ,Elverdi Tugrul,SAYDAM GÜRAY,TOPTAŞ TAYFUR,BİRTAŞ ATEŞOĞLU ELİF,TOPRAK SELAMİ KOÇAK,YILDIRIM RAHŞAN,NALÇACI MELİHA
GERÇEK YAŞAMDA KRONİK LENFOSİTİK LÖSEMİLİHASTALARDA İBRUTİNİB KULLANIMININ ETKİNLİĞİVE GÜVENİLİRLİĞİ: RETROSPEKTİF ÇOK MERKEZLİÇALIŞMANIN SONUÇLARI - TOMBAK ANIL,TANRIKULU PEPEDİL FUNDA,DURUSOY SALİH SERTAÇ,GÜRKAN EMEL,KAYA EMİN,ÜMİT ELİF GÜLSÜM,YAVAŞOĞLU İRFAN,MEHTAP ÖZGÜR,DEVECİ BURAK,ÖZCAN MEHMET ALİ,TERZİ HATİCE,OKAY MÜFİDE,SAYINALP NİLGÜN,YILMAZ MEHMET,OKAN VAHAP,KIZIKLI ALPEREN,ÖZCAN ÖMER,ÇETİN GÜVEN,DEMİRCİOĞLU SİNAN,AYDOĞDU İSMET,SAYDAM GÜRAY,DAVULCU EREN ARSLAN,İLHAN GÜL,UÇAR MEHMET ALİ,ÖZET GÜLSÜM,AKPINAR SEVAL,TURGUT BURHAN,BERBER İLHAMİ,KURTOĞLU ERDAL,SÖNMEZ MEHMET,BATUR SELİM DERYA,YILDIRIM RAHŞAN,ÖZKOCAMAN VİLDAN,GÜNEŞ AHMET KÜRŞAD,SAHİP BİRSEN,ERTOP ŞEHMUS,AKAY OLGA MELTEM,BAŞTÜRK ABDULKADİR,DOĞU MEHMET HİLMİ,AKDENİZ AYDAN,ÜNAL ALİ,ŞEYHANLI AHMET,ÇEKDEMİR DEMET,FERHANOĞLU AHMET BURHAN
GERÇEK YAŞAMDA KRONİK LENFOSİTİK LÖSEMİLİHASTALARDA İBRUTİNİB KULLANIMININ ETKİNLİĞİVE GÜVENİLİRLİĞİ: RETROSPEKTİF ÇOK MERKEZLİÇALIŞMANIN SONUÇLARI - TOMBAK ANIL,Pepedil Tanrıkulu Funda,DURUSOY SALİH SERTAÇ,GÜRKAN EMEL,KAYA EMİN,ÜMİT ELİF GÜLSÜM,YAVAŞOĞLU İRFAN,MEHTAP ÖZGÜR,Deveci Burak,ÖZCAN MEHMET ALİ,TERZİ HATİCE,OKAY MÜFİDE,SAYINALP NİLGÜN,YILMAZ MEHMET,OKAN VAHAP,KIZIKLI ALPEREN,ÖZCAN ÖMER,ÇETİN GÜVEN,DEMİRCİOĞLU SİNAN,AYDOĞDU İSMET,SAYDAM GÜRAY,ARSLAN DAVULCU EREN,İLHAN GÜL,uçar mehmet ali,ÖZET GÜLSÜM,AKPINAR SEVAL,TURGUT BURHAN,BERBER İLHAMİ,KURTOĞLU ERDAL,SÖNMEZ MEHMET,selim batur derya,YILDIRIM RAHŞAN,ÖZKOCAMAN VİLDAN,GÜNEŞ AHMET KÜRŞAT,SAHİP BİRSEN,ERTOP ŞEHMUS,AKAY OLGA MELTEM,BAŞTÜRK ABDÜLKADİR,DOĞU MEHMET HİLMİ,AKDENİZ AYDAN,ÜNAL ALİ,ŞEYHANLI AHMET,ÇEKDEMİR DEMET,FERHANOĞLU AHMET BURHAN
Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study - TOMBAK ANIL,FUNDA PEPEDİL,DURUSOY SALİH SERTAÇ,GÜRKAN EMEL,KAYA EMİN,ÜMİT ELİF GÜLSÜM,YAVAŞOĞLU İRFAN,MEHTAP ÖZGÜR,DEVECİ BURAK,ÖZCAN MEHMET ALİ,TERZİ HATİCE,OKAY MÜFİDE,SAYINALP NİLGÜN,YILMAZ MEHMET,OKAN VAHAP,İKİZLİ ALPEREN,ÖZCAN ÖMER,ÇETİN GÜVEN,DEMİRCİOĞLU SİNAN,AYDOĞDU İSMET,SAYDAM GÜRAY,DAVULCU EREN,İLHAN GÜL,UÇAR MEHMET ALİ,ÖZET GÜLSÜM,AKPINAR SEVAL,TURGUT BURHAN,BERBER İLHAMİ,KURTOĞLU ERDAL,SÖNMEZ MEHMET,BATUR DERYA SELİM,YILDIRIM RAHŞAN,ÖZKOCAMAN VİLDAN,GÜNEŞ AHMET KÜRŞAT,SAHİP BİRSEN,ERTOP ŞEHMUS,AKAY OLGA MELTEM,BAŞTÜRK ABDULKADİR,DOĞU MEHMET HİLMİ,AKDENİZ AYDAN,ÜNAL ALİ,SEYHANLI AHMET,FERHANOĞLU AHMET BURHAN
Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data - DEMİRKAN FATİH,ÇİFTÇİLER RAFİYE,SEVİNDİK ÖMÜR GÖKMEN,TEKGÜNDÜZ ALİ İRFAN EMRE,ERKURT MEHMET ALİ,VURAL FİLİZ,TURGUT BURHAN,KAYNAR LEYLAGÜL,PAYZIN KADRİYE BAHRİYE,DOĞU MEHMET HİLMİ,KARAKUŞ VOLKAN,ALTUNTAŞ FEVZİ,BÜYÜKAŞIK YAHYA
Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data - DEMİRKAN FATİH,CİFTCİLER RAFİYE,SEVİNDİK ÖMÜR GÖKMEN,ERKURT MEHMET ALİ,VURAL FİLİZ,TURGUT BURHAN,KAYNAR LEYLAGÜL,PAYZİN KADRİYE BAHRİYE,DOĞU MEHMET HİLMİ,KARAKUS VOLKAN,ALTUNTAŞ FEVZİ,BÜYÜKAŞIK YAHYA
Ülkemizdeki Paroksismal Nokturnal Hemoglobinüri Hastalarının Klinik Özelliklerinin ve Tedavi Sonuçlarının Değerlendirilmesi Çok Merkezli Bir Çalışma - GÖREN ŞAHİN DENİZ,AKAY OLGA MELTEM,KEKLİK MUZAFFER,OKAN VAHAP,KARAKUŞ ABDULLAH,KARA ERDAL,ERKURT MEHMET ALİ,İLKKILIÇ KADİR,YILDIRIM RAHŞAN,AKGÜN ÇAĞLIYAN GÜLSÜM,AKSU SALİH,DOĞU MEHMET HİLMİ,DAL MEHMET SİNAN,KARAKUŞ VOLKAN,GEMİCİ ALİ İHSAN,TERZİ HATİCE,KELKİTLİ ENGİN,PAMUK GÜLSÜM EMEL,ŞIVGIN SERDAR,ÜNAL ALİ,YILMAZ MEHMET,AYYILDIZ MEHMET ORHAN,DEMİR CENGİZ,KORKMAZ SERDAL,SARI İSMAİL,ESER BÜLENT,ALTUNTAŞ FEVZİ
Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data - DEMİRKAN FATİH,çiftciler Rafiye,SEVİNDİK ÖMÜR GÖKMEN,Tekgündüz Emre,ERKURT MEHMET ALİ,VURAL FİLİZ,TURGUT BURHAN,KAYNAR LEYLAGÜL,PAYZIN KADRİYE BAHRİYE,DOĞU MEHMET HİLMİ,Karakuş Volkan,ALTUNTAŞ FEVZİ,BÜYÜKAŞIK YAHYA
Beta talasemi minör hastaları yorgun değiller, depresif ve anksiyözler - EREN RAFET,Karışmaz Abdülkadir,Aslan Ceyda,DOĞU MEHMET HİLMİ,Altındal Şermin,Yokuş Osman,Suyanı Elif
Lenalidomid ve Desitabin kombinasyonu ile transfüzyon ihtiyacı kalmayan ve blast oranı azalan Del5Q pozitif RAEB-1 hastası - DOĞU MEHMET HİLMİ,EREN RAFET,Suyanı Elif
TÜRKİYE DE TERAPOTİK PLAZMA EXCHANGE AKTİVİTESİ: ULUSAL ARAŞTIRMA - KORKMAZ SERDAL,SOLMAZ ŞERİFE,DEMİRKAN FATİH,BEŞIŞIK SEVGİ,DADIN ALTAY SENEM,AKGÜN ÇAĞLAYAN GÜLSÜM,KABUKÇU HACIOĞLU SİBEL,GÖREN ŞAHİN DENİZ,DAĞDAŞ SİNEM,KUTLU NERMİN,KİPER ÜNAL HATİCE DEMET,GÜNER NAİLE,ÇELİK HALİL,BAY İLKER,ÖZGÜR GÖKHAN,ERKUT MEHMET ALİ,ÖZATLI DÜZGÜN,MELETLİ ÖZGÜR,DEMİRCİOĞLU SİNAN,DEMİR CENGİZ,KURTOĞLU ERDAL,VURAL FİLİZ,TÖBÜ MAHMUT,KARAKUŞ ABDULLAH,AYYILDIZ MEHMET ORHAN,DAL MEHMET SİNAN,AFACAN ÖZTÜRK BERNA,ALBAYRAK MURAT,OCAKÇI SERKAN,BOLAMAN ALİ ZAHİT,SÖNMEZ MEHMET,KARAKUŞ VOLKAN,SEVİNDİK ÖMÜR GÖKMEN,BERBER İLHAMİ,DOĞU MEHMET HİLMİ,GÜLTÜRK EMİNE,ULAŞ TURGAY,PAYZIN KADRİYE BAHRİYE,KUKU İRFAN,ÇAĞIRGAN SEÇKİN,ALTUNTAŞ FEVZİ
REAL-WORLD DATA IN RELAPSED REFRACTORYMYELOMA PATIENTS TREATED WITH CARFILZOMIB,A MULTICENTER TURKISH EXPERIENCE - SEVİNDİK ÖMÜR GÖKMEN,SOLMAZ ŞERİFE,PEHLİVAN MUSTAFA,KAVUKÇU SİBEL,YALNIZ FEVZİ FIRAT,ÖZKOCAMAN VİLDAN,ARAT MUTLU,TURGUT MEHMET,ÖZCAN MUHİT,ÖZSAN GÜNER HAYRİ,ASLAN ÖNDER,SÖNMEZ MEHMET,AYDIN YILDIZ,DOĞU MEHMET HİLMİ
NÜKS VEYA REFRAKTER HODGKİN LENFOMAHASTALARINDA NİVOLUMAB KULLANIMI TÜRKİYE VERİLERİ - FERHANOĞLU AHMET BURHAN,BEKÖZ HÜSEYİN SAFFET,KARADURMUŞ NURİ,PAYDAŞ SEMRA,TÜRKER FATMA ALEV,TOPTAŞ TAYFUR,TUĞLULAR AYŞE TÜLİN,SÖNMEZ MEHMET,Gülbaş Zafer,Tekgündüz Emre,Kaya Ali Hakan,ÖZBALAK MUSTAFA MURAT,Taştemir Naz,KAYNAR LEYLAGÜL,YILDIRIM RAHŞAN,Karadogan İhsan,ARAT MUTLU,Pepedil Tanrıkulu Funda,ÖZKOCAMAN VİLDAN,ABALI HÜSEYİN,YÜKSEL MELTEM,ÖZCAN MUHİT,DOĞU MEHMET HİLMİ,HACIOĞLU SİBEL,BARIŞTA İBRAHİM,DEMİRKAYA METİN,Köseoğlu Fatoş Dilan,TOPRAK SELAMİ KOÇAK,Yılmaz Mehmet,Demirkürek Cengiz,DEMİRKOL MEHMET ONUR
REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH CARFILZOMIB, A MULTICENTER TURKISH EXPERİENCE - SEVİNDİK ÖMÜR GÖKMEN,PEHLİVAN MUSTAFA,TUĞLULAR AYŞE TÜLİN,SOLMAZ ŞERİFE MEDENİ,DOĞU MEHMET HİLMİ,YALNIZ FEVZİ FIRAT,URAL ALİ UĞUR,YEĞEN ZAFER SERENLİ,ARAT MUTLU,ÖZKOCAMAN VİLDAN,ÜMİT ELİF GÜLSÜM,ŞAHİN HANDAN HAYDAROĞLU,SÖNMEZ MEHMET,TURGUT MEHMET,ÖZCAN MUHİT,ARSLAN ÖNDER,AYDIN YILDIZ,ELİBOL TAYFUN,HARMANDALI AYBÜKE,BAYAR BANU,TOMBAK ANIL,AYDOĞDU İSMET,ÖZSAN GÜNER HAYRİ
REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH CARFILZOMIB, A MULTICENTER EXPERİENCE - SEVİNDİK ÖMÜR GÖKMEN,SOLMAZ ŞERİFE MEDENİ,PEHLİVAN MUSTAFA,KABUKLU SİBEL HACIOĞLU,YALNIZ FEVZİ FIRAT,ÖZKOCAMAN VİLDAN,ARAT MUTLU,TURGUT MEHMET,ÖZCAN MUHİT,ARSLAN ÖNDER,SÖNMEZ MEHMET,YILDIZ AYDIN,HAYDAROĞLU HANDAN ŞAHİN,DOĞU MEHMET HİLMİ,TOMBAK ANIL,BAYAR BANU,YARADILMIŞ İBRAHİM MUAZ,ÖZSAN GÜNER HAYRİ
REAL-WORLD DATA IN RELAPSED REFRACTORYMYELOMA PATIENTS TREATED WITH CARFILZOMIB,A MULTICENTER TURKISH EXPERIENCE - SEVİNDİK ÖMÜR GÖKMEN,Solmaz Şerife Medeni,PEHLİVAN MUSTAFA,kabuklu hacıoğlu sibel,YALNIZ FEVZİ FIRAT,ÖZKOCAMAN VİLDAN,ARAT MUTLU,TURGUT MEHMET,ÖZCAN MUHİT,ARSLAN ÖNDER,SÖNMEZ MEHMET,aydın yıldız,Haydarolu Şahin handan,DOĞU MEHMET HİLMİ,TOMBAK ANIL,bayar banu,Yaradılmış ibrahim muaz,ÖZSAN GÜNER HAYRİ
Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience - SEVİNDİK ÖMÜR GÖKMEN,PEHLİVAN MUSTAFA,TUĞLULAR AYŞE TÜLİN,solmaz şerife medeni,DOĞU MEHMET HİLMİ,YALNIZ FEVZİ FIRAT,URAL ALİ UĞUR,yeğen zafer serenli,ARAT MUTLU,ÖZKOCAMAN VİLDAN,ÜMİT ELİF GÜLSÜM,ŞAHİN HANDAN HAYDAROĞLU,SÖNMEZ MEHMET,TURGUT MEHMET,ÖZCAN MUHİT,ARSLAN ÖNDER,AYDIN YILDIZ,ELİBOL TAYFUN,HARMANDALI AYBÜKE,BAYAR BANU,TOMBAK ANIL,AYDOĞDU İSMET,ÖZSAN GÜNER HAYRİ
Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience - SEVİNDİK ÖMÜR GÖKMEN,medeni solmaz şerife,PEHLİVAN MUSTAFA,HACIOĞLU SİBEL,YALNIZ FEVZİ FIRAT,ÖZKOCAMAN VİLDAN,ARAT MUTLU,TURGUT MEHMET,ÖZCAN MUHİT,ARSLAN ÖNDER,SÖNMEZ MEHMET,yıldız aydın,HAYDAROĞLU ŞAHİN HANDAN,DOĞU MEHMET HİLMİ,TOMBAK ANIL,bayar banu,yaradılmış ibrahim muaz,ÖZSAN GÜNER HAYRİ
Lenalidomide Plus Decitabine Treatment in a Del5Q Patient with RAEB-1 and Response in the Dependency to Transfusion and Blast Ratio - DOĞU MEHMET HİLMİ,EREN RAFET,SUYANI ELİF
Autoimmune Manifestation in Myelodysplastic Syndrome - HACIOĞLU SİBEL,DOĞU MEHMET HİLMİ,SARI İSMAİL,KESKİN ALİ
MANAGEMENT OF MANTLE CELL LYMPHOMA IN THE ELDERLY: A RETROSPECTIVE MULTICENTER STUDY - KEKLİK MUZAFFER,DOĞU MEHMET HİLMİ,NİZAM İLKNUR,TERZİ HATİCE,HACIOĞLU SİBEL,ERKURT MEHMET ALİ,KESKİN ALİ,ESER BÜLENT,ÇETİN MUSTAFA,ÜNAL ALİ,İLHAN OSMAN
Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes - DOĞU MEHMET HİLMİ,KEKLİK MUZAFFER,TERZİ HATİCE,KORKMAZ SERDAL,ERKURT MEHMET ALİ,AKGÜN ÇAĞLIYAN GÜLSÜM,KAYNAR LEYLAGÜL,ŞIVGIN SERDAR,SARI İSMAİL,KESKİN ALİ,ŞENCAN MEHMET,ALTUNTAŞ FEVZİ,İLHAN OSMAN
Herediter Hemorajik Telenjiektazi Olgusunda Sistemik Bevacizumab Kullanımı Sonrası Transfüzyon İhtiyacında Dramatik Azalma - DOĞU MEHMET HİLMİ,SARI İSMAİL,HACIOĞLU SİBEL,ERTÜRK SEMA,KESKİN ALİ
Yaşlı Akut Miyeloid Lösemili Hastaların Tedavisinde 5-Azasitidin Tedavisinin Etkinliği - TOMBAK ANIL,UÇAR MEHMET ALİ,AKDENİZ AYDAN,TİFTİK EYÜP NACİ,GÖREN ŞAHİN DENİZ,AKAY OLGA MELTEM,YILDIRIM MURAT,NEVRUZ ORAL,KİS CEM,GÜRKAN EMEL,MEDENİ SOLMAZ ŞERİFE,ÖZCAN MEHMET ALİ,YILDIRIM RAHŞAN,BERBER İLHAMİ,ERKURT MEHMET ALİ,TUĞLULAR AYŞE TÜLİN,TARKUN PINAR,YAVAŞOĞLU İRFAN,DOĞU MEHMET HİLMİ,SARI İSMAİL,MERTER MUSTAFA,ÖZCAN MUHİT,YILDIZHAN ESRA,KAYNAR LEYLAGÜL,MEHTAP ÖZGÜR,UYSAL AYŞE,ŞAHİN FAHRİ,SALİM OZAN,SUNGUR MEHMET ALİ
İleri Evre DBBHL Tanısı ile Kemoterapi Tedavi Alırken SSS Tutulumu Gelişen ve Menenjit ile Karışan Bir Olgu - EREN RAFET,YOKUŞ OSMAN,ASLAN CEYDA,DOĞU MEHMET HİLMİ,SUYANI ELİF
CD 56, CD34, CD117 ve CD33 Ekspresyonu Gösteren T-Hücreli Akut Lenfoblastik Lösemi Kötü gidişili bir Olgu - EREN RAFET,ASLAN CEYDA,DOĞU MEHMET HİLMİ,YOKUŞ OSMAN,SUYANI ELİF
Hodgkin Lenfoma Hastalarında İnterim ve Tedavi Sonrası PET Yanıtlarının lenf Nodu Boyutu ile Olan İlişkisi - EREN RAFET,GÜNDOĞAN CİHAN,ASLAN CEYDA,KOÇ ALPER,DOĞU MEHMET HİLMİ,ALTINDAL ŞERMİN,YOKUŞ OSMAN,ÇERMİK TEVFİK FİKRET,SUYANI ELİF
Polistemia Vera ve Esansiyel Trombositemi Risk Değerlendirmesinde Karotis İntima Media Kalınlığının Potansiyel Rolü - BAYRAK MURAT,KAYA ORHAN,EREN RAFET,DOĞU MEHMET HİLMİ,ALTINDAL ŞERMİN,YOKUŞ OSMAN,KILIÇKESMEZ NURİ ÖZGÜR,SUYANI ELİF
Nötrofil Lenfosit Oranı İmmun Trombositopenili Hastalarda Steroid Tedavisine Yanıtı Öngörebilirmi? - EREN RAFET,ÜNALDI MEHMET,KARIŞMAZ ABDULKADİR,DOĞU MEHMET HİLMİ,TAN KÖKER HİLAL,ALTINDAL ŞERMİN,YOKUŞ OSMAN,SUYANI ELİF
Meme Kanseri Nüksüyle Ortaya Çıkan Bir Diffüz Büyük B Hücreli Lenfoma Olgusu - KARIŞMAZ ABDULKADİR,DOĞU MEHMET HİLMİ,ERDEM HUQ GÜLBEN,ALTINDAL ŞERMİN,YOKUŞ OSMAN,SUYANI ELİF
Lökoferez ve Hidroksiüre Tedavisine Yanıtsız Hiperlökositozlu Akut Myeloid Lösemili Hastada Yüksek Doz Steroid Tedavisi - KOÇ ALPER,DOĞU MEHMET HİLMİ,TAN KÖKER HİLAL,AKPINAR SEVAL,YOKUŞ OSMAN,ALTINDAL ŞERMİN,SUYANI ELİF
Multipl Myelom’da Tanı Anı Globulin Düzeyi İle Tedavi Yanıtı ve Sağ Kalım Arasındaki İlişki - EREN RAFET,ÖZDEMİR ÖZLEM,ASLAN CEYDA,DOĞU MEHMET HİLMİ,ALTINDAL ŞERMİN,YOKUŞ OSMAN,SUYANI ELİF
Steroid ve IVIG Yanıtsız İmmun Trombositopeni Hastalarında Splenektomiye Köprü Olarak Eltrombopag Tedavisi İki Olgu - ASLAN CEYDA,EREN RAFET,DOĞU MEHMET HİLMİ,YOKUŞ OSMAN,ALTINDAL ŞERMİN,SUYANI ELİF
REAL-WORLD DATA IN RELAPSED REFRACTORYMYELOMA PATIENTS TREATED WITH CARFILZOMIB,A MULTICENTER TURKISH EXPERIENCE - SEVİNDİK ÖMÜR GÖKMEN,medeni solmaz şerife,PEHLİVAN MUSTAFA,HACIOĞLU SİBEL,YALNIZ FEVZİ FIRAT,ÖZKOCAMAN VİLDAN,ARAT MUTLU,TURGUT MEHMET,ÖZCAN MUHİT,ARSLAN ÖNDER,SÖNMEZ MEHMET,aydın yıldız,HAYDAROĞLU ŞAHİN HANDAN,DOĞU MEHMET HİLMİ,TOMBAK ANIL,bayar banu,yaradılmış ibrahim,ÖZSAN GÜNER HAYRİ
Yeni Tanı Akut Lösemi Hastalarında Anksiyete ve Depresyonun Farkındamıyız? - DOĞU MEHMET HİLMİ,YILMAZ ELİF EBRU,EREN RAFET,ASLAN CEYDA,YOKUŞ OSMAN,SUYANI ELİF
Fludarabin Refrakter Akut Lösemi Hastalarında Düşük Doz Klofarabin/ ARA-C Kullanımı: Tek merkez Deneyimi - DOĞU MEHMET HİLMİ,HACIOĞLU SİBEL,SARI İSMAİL,KESKİN ALİ
